Rite Aid Closing More Locations After Bankruptcy Filing
Rite Aid, once a towering figure in the American pharmacy landscape, is now staggering under the weight of its own collapse—and the latest news only sharpens the sense of a slow, painful descent into bankruptcy. In a new filing dated July 18 in New Jersey, Rite Aid announced its 12th wave of store closures, marking an additional 17 locations set to shutter across six states before the end of the year.
From Dominance to Decline and Bankruptcy
For a company that was once synonymous with convenience and community healthcare, the trajectory has been nothing short of dramatic. Founded in 1962 in Pennsylvania, Rite Aid quickly rose through the ranks to become one of the country’s leading pharmaceutical chains. By 2008, it boasted more than 5,000 stores, cementing its position as the third-largest pharmacy in the U.S. But that peak was followed by a prolonged period of stagnation, mismanagement, and mounting debt.
By the time Rite Aid filed for bankruptcy in 2023, it had dwindled to just over 2,100 stores and a desperate need for financial lifelines. The company secured a whopping $3.45 billion in new financing and managed to eliminate $2 billion in debt, a maneuver that seemed promising. With another $2.5 billion in exit financing, a fragile optimism began to emerge.
Restructuring Gone Wrong
However, the restructuring plan—ambitious on paper—fell apart in execution. By April 2024, the dominoes were falling again, and whispers of a second bankruptcy turned into concrete plans. What followed was a steady purge of real estate and retail presence. The company now teeters on the edge of erasure.
Yet Rite Aid isn’t disappearing in a vacuum. CVS and Walgreens, their long-time rivals, have been quick to absorb what’s left. CVS picked up 625 Rite Aid pharmacies and 64 stores in key western states, only to announce its own round of closures: 270 locations nationwide as it trims down amid changing consumer behaviors and regulatory crackdowns.
The Fallout Spreads Beyond Rite Aid
Arkansas is at the forefront of a new wave of uncertainty. A law banning Pharmacy Benefit Managers (PBMs) from owning or operating pharmacies—effective in 2026—has placed all 23 CVS locations in the state in jeopardy. A similar bill in Louisiana suggests CVS could lose even more territory.
Meanwhile, Walgreens, in a separate move to secure its future, is finalizing a $10 billion deal with Sycamore Partners to go private—an escape route from the pressures of public trading. That deal also includes the acquisition of additional Rite Aid properties. Other retail players, such as Albertsons and Kroger, have picked through the remaining assets, salvaging what they can.
Rite Aid’s collapse, however, is more than a story of one chain’s demise. It’s a case study in how swiftly retail healthcare can unravel in a volatile landscape, where debt, regulation, and shifting models of care can demolish even the longest-standing institutions.
